BACKGROUND
Molecular glues to unlock new target space.
Harnessing protein interactions to create therapeutically relevant ternary complexes — and new opportunities for patients.
THE OPPORTUNITY
From chance to a systematic approach
Historically, molecular glues were found by chance, not by design. Identifying the right target–effector pair, detecting hits for chemistry starting points and translating them into potent molecules remain major challenges.
THE CHALLENGE
Discovery by design, not serendipity.
KiloGen’s GRIP platform brings target selection, glue-ability assessment and sensitive screening together to find new starting points for drug discovery.
Discover the GRIP platform